Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
2017 · Gastroenterology · 505 citations
https://doi.org/10.1053/j.gastro.2017.02.038
K
Kidist Yimam
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.1K
Citations
12
h-index
14
i10-index
Kidist Yimam is an academic researcher from California Pacific Medical Center. The author has contributed to research in topics: Liver Diseases and Immunity & Liver Disease Diagnosis and Treatment & Gallbladder and Bile Duct Disorders. The author has an h-index of 12, co-authored 45 publications.
Papers by this author
worksEffects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
2019 · Clinical Gastroenterology and Hepatology · 97 citations
https://doi.org/10.1016/j.cgh.2019.05.013
Alkaline Phosphatase Changes With Seladelpar Across Subgroups Of Primary Biliary Cholangitis Patients In The Response Trial
2025 · Digestive and Liver Disease · 2 citations
https://doi.org/10.1016/j.dld.2025.01.171
3 EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE ASSURE STUDY: INTERIM RESULTS
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)03986-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat